Saxenda and Victoza contain the exact same active ingredient, liraglutide, but at different maximum doses and for different approved purposes: Saxenda is for weight management, Victoza is for type 2 diabetes. This guide explains what that same-drug, different-purpose relationship actually means in practice.
This is general information, not medical advice.
Saxenda vs Victoza at a glance
| Saxenda (liraglutide) | Victoza (liraglutide) | |
|---|---|---|
| Active ingredient | Liraglutide | Liraglutide (same molecule) |
| FDA-approved for | Chronic weight management | Type 2 diabetes, cardiovascular risk reduction |
| Maximum dose | 3.0 mg once daily | 1.8 mg once daily |
| Approved ages | Adults, adolescents 12-17 with obesity | Adults and children 10+ with type 2 diabetes |
| Drug class | GLP-1 receptor agonist | GLP-1 receptor agonist |
Same molecule, different dose and purpose
This is the single most important fact about this comparison: Saxenda and Victoza both contain liraglutide, made by the same manufacturer, working through the identical GLP-1 receptor agonist mechanism. The difference is the maximum approved dose and the specific condition each is FDA-approved to treat. Saxenda is dosed up to 3.0 mg daily and approved for chronic weight management in adults with obesity or overweight plus a weight-related condition, and in adolescents 12 to 17 with obesity and a body weight above 60 kg. Victoza tops out at 1.8 mg daily and is approved to improve blood sugar control in type 2 diabetes (adults and children 10 and older), and to reduce the risk of major cardiovascular events in adults with type 2 diabetes and known heart disease.
The label for Saxenda specifically states it isn’t recommended for people also taking liraglutide or other GLP-1 receptor agonist medicines, meaning Saxenda and Victoza should never be combined, since that would mean double-dosing the same active drug through two products.
How liraglutide works
As a GLP-1 receptor agonist, liraglutide mimics the natural GLP-1 hormone, increasing insulin secretion and decreasing glucagon secretion in a glucose-dependent way, slowing gastric emptying, and acting on brain appetite centers, the shared mechanism responsible for both its blood-sugar-lowering effect (relevant to Victoza’s diabetes indication) and its appetite-suppressing, weight-loss effect (relevant to Saxenda’s use).
Why the dose difference matters
Saxenda’s higher maximum dose (3.0 mg versus Victoza’s 1.8 mg) reflects that a stronger appetite-suppressing, weight-loss-focused effect generally requires a higher liraglutide dose than what’s needed for blood sugar control alone. Patients switching from Victoza (diabetes) to Saxenda (weight loss) because they also want the weight benefit, or the reverse, should understand these are different approved products with different dosing schedules, not simply the same prescription at a different label.
Side effects
Both share the class-wide GLP-1 side effect profile: nausea, diarrhea, vomiting, decreased appetite, indigestion, and constipation, generally listed as the most common side effects for both Saxenda and Victoza. Both carry the same boxed warning regarding thyroid C-cell tumors observed in rodent studies, with human relevance undetermined, a warning shared across the entire liraglutide (and broader GLP-1) product family.
Who each might suit
Factors that may point toward Saxenda:
- The primary goal is weight loss, without necessarily having type 2 diabetes
- Being an adolescent 12-17 with obesity, where Saxenda has a specific approval pathway
Factors that may point toward Victoza:
- A type 2 diabetes diagnosis needing blood sugar control
- Known cardiovascular disease alongside type 2 diabetes, given Victoza’s cardiovascular risk-reduction indication
- Being a child 10 or older with type 2 diabetes, where Victoza has a specific pediatric approval
Frequently asked questions
Are Saxenda and Victoza the same drug?
Yes, both contain liraglutide, made by the same company, but at different maximum doses (3.0 mg for Saxenda, 1.8 mg for Victoza) and approved for different primary purposes (weight loss versus diabetes).
Can I take Saxenda and Victoza together?
No. Saxenda’s label specifically advises against combining it with other liraglutide or GLP-1 receptor agonist products, since that would mean double-dosing the same drug.
Which has a higher dose, Saxenda or Victoza?
Saxenda, at up to 3.0 mg daily, versus Victoza’s maximum of 1.8 mg daily, reflecting Saxenda’s weight-loss-focused higher dosing.
Is Victoza approved for children?
Yes, for type 2 diabetes in children 10 and older. Saxenda has a separate adolescent approval (ages 12-17) specifically for obesity/weight management.
Do both carry the thyroid tumor warning?
Yes, both carry the same boxed warning about thyroid C-cell tumors seen in rodent studies, since they share the same active ingredient.